Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) shares rose 13.9% on Wednesday . The company traded as high as $2.24 and last traded at $2.21. Approximately 133,344 shares were traded during mid-day trading, a decline of 46% from the average daily volume of 247,025 shares. The stock had previously closed at $1.94. Revelation Biosciences […]
Revelation Biosciences, Inc. (NASDAQ:REVBW – Get Free Report) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 1,300 shares, a decrease of 23.5% from the March 31st total of 1,700 shares. Based on an average daily volume of 78,500 shares, the days-to-cover ratio […]
Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 18,500 shares, a decrease of 43.6% from the March 31st total of 32,800 shares. Based on an average daily volume of 391,900 shares, […]
Revelation Biosciences, Inc. (NASDAQ:REVB) Forecasted to Post Q1 2024 Earnings of ($1.77) Per Share theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Revelation Biosciences (NASDAQ:REVB – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($8.33) earnings per share (EPS) for the quarter, beating the consensus estimate of ($10.94) by $2.61, reports. Revelation Biosciences Stock Performance Shares of REVB traded down $0.01 during midday trading on Monday, hitting $2.36. 23,211 shares of the […]